Skip to content

Increased risk of oral contraceptive failure with nelfinavir

Keeping viral load below 20,000 copies/ml still beneficial, even after HIV rebound

Therapy with an HIV vaccine: progress poor, prospects unclear

WHO issues guidance on what to do about delisted ARVs

Slow but real progress on antibodies against HIV

Viral load one month after starting HAART predicts who will be detectable after six months treatment

WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

Merck's Ad5 is AIDS vaccine most likely to test concept

Measles vaccine proposed for global AIDS protection